Article | Published:

Notch-modifying xylosyltransferase structures support an SNi-like retaining mechanism

Nature Chemical Biology volume 11, pages 847854 (2015) | Download Citation


A major question remaining in glycobiology is how a glycosyltransferase (GT) that retains the anomeric linkage of a sugar catalyzes the reaction. Xyloside α-1,3-xylosyltransferase (XXYLT1) is a retaining GT that regulates Notch receptor activation by adding xylose to the Notch extracellular domain. Here, using natural acceptor and donor substrates and active Mus musculus XXYLT1, we report a series of crystallographic snapshots along the reaction, including an unprecedented natural and competent Michaelis reaction complex for retaining enzymes. These structures strongly support the SNi-like reaction as the retaining mechanism for XXYLT1. Unexpectedly, the epidermal growth factor–like repeat acceptor substrate undergoes a large conformational change upon binding to the active site, providing a structural basis for substrate specificity. Our improved understanding of this retaining enzyme will accelerate the design of retaining GT inhibitors that can modulate Notch activity in pathological situations in which Notch dysregulation is known to cause cancer or developmental disorders.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.



  1. 1.

    & The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216–233 (2009).

  2. 2.

    , , & From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell 25, 318–334 (2014).

  3. 3.

    & Significance of glycosylation in Notch signaling. Biochem. Biophys. Res. Commun. 453, 235–242 (2014).

  4. 4.

    et al. Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling. Cell 132, 247–258 (2008).

  5. 5.

    et al. Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi. Development 138, 1925–1934 (2011).

  6. 6.

    et al. Rumi functions as both a protein O-glucosyltransferase and a protein O-xylosyltransferase. Proc. Natl. Acad. Sci. USA 108, 16600–16605 (2011).

  7. 7.

    et al. Identification of glycosyltransferase 8 family members as xylosyltransferases acting on O-glucosylated Notch epidermal growth factor repeats. J. Biol. Chem. 285, 1582–1586 (2010).

  8. 8.

    et al. Molecular cloning of a xylosyltransferase that transfers the second xylose to O-glucosylated epidermal growth factor repeats of Notch. J. Biol. Chem. 287, 2739–2748 (2012).

  9. 9.

    et al. Negative regulation of Notch signaling by xylose. PLoS Genet. 9, e1003547 (2013).

  10. 10.

    , , , & The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res. 42, D490–D495 (2014).

  11. 11.

    , , & Glycosyltransferases: structures, functions and mechanisms. Annu. Rev. Biochem. 77, 521–555 (2008).

  12. 12.

    , & Recent structures, evolution and mechanisms of glycosyltransferases. Curr. Opin. Struct. Biol. 22, 540–549 (2012).

  13. 13.

    & Recent structural and mechanistic insights into post-translational enzymatic glycosylation. Curr. Opin. Chem. Biol. 16, 479–487 (2012).

  14. 14.

    et al. Conformational plasticity of glycogenin and its maltosaccharide substrate during glycogen biogenesis. Proc. Natl. Acad. Sci. USA 108, 21028–21033 (2011).

  15. 15.

    et al. Mechanistic evidence for a front-side, SNi-type reaction in a retaining glycosyltransferase. Nat. Chem. Biol. 7, 631–638 (2011).

  16. 16.

    et al. Substrate-guided front-face reaction revealed by combined structural snapshots and metadynamics for the polypeptide N-acetylgalactosaminyltransferase 2. Angew. Chem. Int. Ed. Engl. 53, 8206–8210 (2014).

  17. 17.

    et al. Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs. Nat. Struct. Biol. 8, 166–175 (2001).

  18. 18.

    et al. Mechanistic insight into enzymatic glycosyl transfer with retention of configuration through analysis of glycomimetic inhibitors. Angew. Chem. Int. Ed. Engl. 49, 1234–1237 (2010).

  19. 19.

    , , , & Site-specific O-glucosylation of the epidermal growth factor-like (EGF) repeats of Notch: efficiency of glycosylation is affected by proper folding and amino acid sequence of individual EGF repeats. J. Biol. Chem. 287, 33934–33944 (2012).

  20. 20.

    et al. Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands. Proc. Natl. Acad. Sci. USA 111, 7290–7295 (2014).

  21. 21.

    et al. Detection of UDP-d-xylose: alpha-d-xyloside α1→3xylosyltransferase activity in human hepatoma cell line HepG2. J. Biochem. 120, 1002–1006 (1996).

  22. 22.

    & Activity of the yeast MNN1 α-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. Proc. Natl. Acad. Sci. USA 95, 7945–7950 (1998).

  23. 23.

    et al. Evolution of distinct EGF domains with specific functions. Protein Sci. 14, 1091–1103 (2005).

  24. 24.

    et al. The structure of a Ca2+-binding epidermal growth factor–like domain: its role in protein-protein interactions. Cell 82, 131–141 (1995).

  25. 25.

    et al. A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat. Struct. Mol. Biol. 15, 849–857 (2008).

  26. 26.

    , , , & Synthesis and conformational characterization of the epidermal growth factor–like domain of blood coagulation factor IX carrying xylosyl-glucose. Glycoconj. J. 21, 197–203 (2004).

  27. 27.

    , , , & Human factor IX has a tetrasaccharide O-glycosidically linked to serine 61 through the fucose residue. J. Biol. Chem. 267, 17520–17525 (1992).

  28. 28.

    et al. Intermediate trapping on a mutant retaining α-galactosyltransferase identifies an unexpected aspartate residue. J. Biol. Chem. 279, 28339–28344 (2004).

  29. 29.

    , & Geometric attributes of retaining glycosyltransferase enzymes favor an orthogonal mechanism. PLoS ONE 8, e71077 (2013).

  30. 30.

    , , , & Retaining glycosyltransferase mechanism studied by QM/MM methods: lipopolysaccharyl-α-1,4-galactosyltransferase C transfers α-galactose via an oxocarbenium ion–like transition state. J. Am. Chem. Soc. 134, 4743–4752 (2012).

  31. 31.

    et al. A novel tumor suppressor function for the Notch pathway in myeloid leukemia. Nature 473, 230–233 (2011).

  32. 32.

    et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 108, 17761–17766 (2011).

  33. 33.

    et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154–1157 (2011).

  34. 34.

    et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401–404 (2012).

  35. 35.

    & The molecular mechanism of enzymatic glycosyl transfer with retention of configuration: evidence for a short-lived oxocarbenium-like species. Angew. Chem. Int. Ed. Engl. 50, 10897–10901 (2011).

  36. 36.

    & in Carbohydrate-Based Drug Discovery (ed. Wong, C.-H.) 609–659 (Wiley-VCH, 2003).

  37. 37.

    & Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology. Nat. Chem. Biol. 8, 683–694 (2012).

  38. 38.

    & Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).

  39. 39.

    et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).

  40. 40.

    , , & Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).

  41. 41.

    & Molecular replacement with MOLREP. Acta Crystallogr. D Biol. Crystallogr. 66, 22–25 (2010).

  42. 42.

    , , & Incorporation of prior phase information strengthens maximum-likelihood structure refinement. Acta Crystallogr. D Biol. Crystallogr. 54, 1285–1294 (1998).

  43. 43.

    et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 (2011).

  44. 44.

    The PyMOL Molecular Graphics System, Version 1.3r1 (2010).

  45. 45.

    et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).

  46. 46.

    & Mechanisms of tryptophan fluorescence shifts in proteins. Biophys. J. 80, 2093–2109 (2001).

  47. 47.

    et al. Relaxation dynamics of tryptophan in water: A UV fluorescence up-conversion and molecular dynamics study. J. Phys. Chem. A 114, 9034–9042 (2010).

Download references


We thank members of the Li and Haltiwanger labs for critical comments on this work. The work was supported by US National Institutes of Health grants GM061126 (R.S.H.) and AG029979 (H.L.), Stony Brook University–Brookhaven National Laboratory Seed grant (R.S.H. and H.L.), German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) grant BA4091/5-1 (H.B.) and National Science Foundation grant DMR 1404985 (E.L.). We acknowledge access to beamlines X25, X29 and X6A at the National Synchrotron Light Source (NSLS) and thank the staff at these beamlines. NSLS were supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-98CH10886. UDP-xylose isolation by the Carbosource Services at the Complex Carbohydrate Research Center, University of Georgia was supported in part by the US Department of Energy grant DE-FG02-93ER20097. The results published here are in part based upon data generated by the Cancer Genome Atlas Research Network (

Author information

Author notes

    • Megumi Takeuchi
    • , Robert S Haltiwanger
    •  & Hideyuki Takeuchi

    Present address: Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.


  1. Biosciences Department, Brookhaven National Laboratory, Upton, New York, USA.

    • Hongjun Yu
    •  & Huilin Li
  2. Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York, USA.

    • Megumi Takeuchi
    • , Joshua Kantharia
    • , Erwin London
    • , Robert S Haltiwanger
    • , Huilin Li
    •  & Hideyuki Takeuchi
  3. Department of Physiology and Biophysics, Stony Brook University, Stony Brook, New York, USA.

    • Jamie LeBarron
  4. Department of Cellular Chemistry, Hannover Medical School, Hannover, Germany.

    • Hans Bakker


  1. Search for Hongjun Yu in:

  2. Search for Megumi Takeuchi in:

  3. Search for Jamie LeBarron in:

  4. Search for Joshua Kantharia in:

  5. Search for Erwin London in:

  6. Search for Hans Bakker in:

  7. Search for Robert S Haltiwanger in:

  8. Search for Huilin Li in:

  9. Search for Hideyuki Takeuchi in:


H.Y., H.B., R.S.H., H.L. and H.T. designed the research. H.Y. prepared the complexes, performed crystallization and solved the structures. H.Y. and H.L. analyzed the structures. M.T. and H.T. expressed and purified proteins and mutants, and performed the enzymatic assays. H.Y., R.S.H., H.L. and H.T. designed the mutants, analyzed the mutant data, performed the cancer-related analysis and wrote the paper. J.L., J.K. and E.L. joined this project after the original submission of the manuscript and contributed to the biophysical experiments regarding the folding status of wild-type and mutated XXYLT1 proteins, which was essential for the revisions to the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Huilin Li or Hideyuki Takeuchi.

Supplementary information

About this article

Publication history





Further reading